BETAMETHASONE
Ataxia Telangiectasia
Grace Therapeutics Inc.Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Ataxia Telangiectasia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ARG Johann Wolfgang Goethe University Hospital | Phase 4 | BB |
17-beta-estradiol Johann Wolfgang Goethe University Hospital | Phase 4 | BB |
ROPIVACAINE Quince Therapeutics S.p.A. | Phase 3 | BB |
Genotropin Johann Wolfgang Goethe University Hospital | Phase 4 | BB |
DEXAMETHASONE Quince Therapeutics S.p.A. | Phase 3 | B |
View all 13 →
Same molecule, other indications
BETAMETHASONE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →